Royalty Pharma Plc (RPRX)
61.33
+0.02
(+0.03%)
USD |
NASDAQ |
Aug 24, 16:00
61.32
-0.01
(-0.02%)
After-Hours: 20:00
Royalty Pharma Price to Book Value : 4.001 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 4.001 |
| August 21, 2026 | 4.000 |
| August 20, 2026 | 3.952 |
| August 19, 2026 | 4.027 |
| August 18, 2026 | 3.894 |
| August 17, 2026 | 3.878 |
| August 14, 2026 | 3.823 |
| August 13, 2026 | 3.820 |
| August 12, 2026 | 3.863 |
| August 11, 2026 | 3.77 |
| August 10, 2026 | 3.782 |
| August 07, 2026 | 3.704 |
| August 06, 2026 | 3.735 |
| August 05, 2026 | 3.767 |
| August 04, 2026 | 3.750 |
| August 03, 2026 | 3.730 |
| July 31, 2026 | 3.812 |
| July 30, 2026 | 3.850 |
| July 29, 2026 | 3.861 |
| July 28, 2026 | 3.912 |
| July 27, 2026 | 3.831 |
| July 24, 2026 | 3.838 |
| July 23, 2026 | 3.850 |
| July 22, 2026 | 3.831 |
| July 21, 2026 | 3.811 |
| Date | Value |
|---|---|
| July 20, 2026 | 3.738 |
| July 17, 2026 | 3.796 |
| July 16, 2026 | 3.818 |
| July 15, 2026 | 3.674 |
| July 14, 2026 | 3.632 |
| July 13, 2026 | 3.683 |
| July 10, 2026 | 3.681 |
| July 09, 2026 | 3.781 |
| July 08, 2026 | 3.808 |
| July 07, 2026 | 3.771 |
| July 06, 2026 | 3.713 |
| July 02, 2026 | 3.769 |
| July 01, 2026 | 3.639 |
| June 30, 2026 | 3.658 |
| June 29, 2026 | 3.677 |
| June 26, 2026 | 3.621 |
| June 25, 2026 | 3.522 |
| June 24, 2026 | 3.496 |
| June 23, 2026 | 3.565 |
| June 22, 2026 | 3.45 |
| June 18, 2026 | 3.411 |
| June 17, 2026 | 3.458 |
| June 16, 2026 | 3.491 |
| June 15, 2026 | 3.495 |
| June 12, 2026 | 3.534 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| AstraZeneca PLC | 10.92 |
| Johnson & Johnson | 7.738 |
| Viatris, Inc. | 1.340 |
| ANI Pharmaceuticals, Inc. | 2.853 |
| Corcept Therapeutics, Inc. | 18.84 |
Price to Book Value Related Metrics
| PE Ratio | 32.65 |
| PS Ratio | 12.71 |
| Price to Free Cash Flow | 52.62 |
| Price | 61.33 |
| Earnings Yield | 3.06% |
| Market Cap | 27.34B |
| Operating PE Ratio | 20.39 |
| Normalized PE Ratio | 34.72 |